Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ·Healthcare·Biotechnology
$20.18
+0.15%
Mkt Cap $3.40B
Analyst Ratings
Buy
21
Hold
3
Sell
0
Price Target (77 analysts)
$32.32
Range $14.50 – $49.00
Implied Upside
+60.2%
Consensus $32.32 vs current $20.18
NASDAQ·Healthcare·Biotechnology
$20.18
+0.15%
Mkt Cap $3.40B
Buy
21
Hold
3
Sell
0
Price Target (77 analysts)
$32.32
Range $14.50 – $49.00
+60.2%
Consensus $32.32 vs current $20.18